In septic patients, elevated LPS levels correlate with both increased IL-6 concentrations and worse severity of acute kidney injury (AKI), and targeted antibacterial therapy (e.g., carbapenems) reduces both bacteremia and cytokine-driven organ damage. The gene discussed is IL6; the disease is acute kidney injury.